Clinical Trials
3 trialsNCT02905994 2018-05-04
Volasertib Combined With Induction Chemotherapy in Acute Myeloid Leukemia
Massachusetts General Hospital
Phase 1 Withdrawn
NCT02680951 2018-04-19
Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia
Emory University
Phase 1 Withdrawn
NCT02527174 2017-04-05
VIAC
University of Alberta
Phase 1 Withdrawn